Explore the words cloud of the EU-TOPIA project. It provides you a very rough idea of what is the project "EU-TOPIA" about.
The following table provides information about the project.
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
|Coordinator Country||Netherlands [NL]|
|Total cost||2˙995˙683 €|
|EC max contribution||2˙995˙683 € (100%)|
1. H2020-EU.3.1.2. (Preventing disease)
|Duration (year-month-day)||from 2015-09-01 to 2020-08-31|
Take a look of project's partnership.
|1||ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM||NL (ROTTERDAM)||coordinator||1˙613˙687.00|
|2||AZIENDA OSPEDALIERA CITTA DELLA SALUTE E DELLA SCIENZA DI TORINO||IT (TORINO)||participant||309˙025.00|
|3||LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER||UK (LONDON)||participant||298˙405.00|
|4||SYREON KUTATO INTEZET KORLATOLT FELELOSSEGU TARSASAG||HU (BUDAPEST)||participant||253˙250.00|
|5||SUOMEN SYOPAYHDISTYS -CANCERFORENINGEN I FINLAND RY - CANCER SOCIETY OF FINLAND CSF||FI (HELSINKI)||participant||245˙000.00|
|6||ONKOLOSKI INSTITUT LJUBLJANA||SI (LJUBLJANA)||participant||172˙440.00|
|7||TERVISE ARENGU INSTITUUT||EE (TALLINN)||participant||103˙875.00|
Breast, colorectal and cervical cancer cause 250,000 deaths each year, representing 20% of EU-cancer mortality. Although important progress has been made in both detection and treatment, there is persisting inequity in progress to reduce its burden. Screening programmes vary substantially between countries and in most long-term effectiveness of screening has not yet been assessed. The objective of EU-TOPIA is to systematically evaluate and quantify the harms and benefits of the running programmes for breast, cervical, and colorectal cancer in all European countries, and identify ways to improve health outcomes and equity for citizens. We will first identify significant inequities in screening outcomes by assessing the key set of quality indicators for benefits and harms in each country. Using these indicators, outcomes and cost-effectiveness of existing cancer screening programmes in 2015 will be estimated. For this, state-of-the-art models of the natural history of the cancers will be constructed, using country-specific data with and from country-specific experts. Barriers hindering implementation of optimal screening programs will be assessed, leading to road maps for improved screening. These road maps contain feasible changes, e.g., to extend or reduce the program, to change the screen test used or change key quality indicators, to perform activities that reduce screen-related harm or incorporate new developments in screening, and provide policymakers with evidence for increased, decreased or optimized use of screening. Capacity for self-evaluation of screening will be built using three web-based tools (monitoring, model-quantification and barrier assessment) explained and trained in workshops with country representatives, also from the Associated Countries. The project will lead to reduced inequity, reduced number of cancer deaths and over-diagnosed cases, and increase in life years gained and better cost-effectiveness by 2025. That is why we call it EU-TOPIA.
|year||authors and title||journal||last update|
Marcell CsanÃ¡di, Inge MCM de Kok, Eveline AM Heijnsdijk, Ahti Anttila, Sirpa HeinÃ¤vaara, JÃ¡nos G Pitter, GyÃ¶rgy SzÃ©les, UrÅ¡ka IvanuÅ¡, Jennifer Priaulx, Piret Veerus, Carlo Senore, Harry J de Koning, ZoltÃ¡n VokÃ³
Key indicators of organized cancer screening programs: Results from a Delphi study
published pages: 120-126, ISSN: 0969-1413, DOI: 10.1177/0969141318820362
|Journal of Medical Screening 26/3||2020-04-15|
Jennifer Priaulx, Eleanor Turnbull, Eveline Heijnsdijk, Marcell CsanÃ¡di, Carlo Senore, Harry J de Koning, Martin McKee
The influence of health systems on breast, cervical and colorectal cancer screening: an overview of systematic reviews using health systems and implementation research frameworks
published pages: 49-58, ISSN: 1355-8196, DOI: 10.1177/1355819619842314
|Journal of Health Services Research & Policy 25/1||2020-04-15|
Erik E.L. Jansen, Nadine Zielonke, Andrea Gini, Ahti Anttila, Nereo Segnan, ZoltÃ¡n VokÃ³, UrÅ¡ka IvanuÅ¡, Martin McKee, Harry J. de Koning, Inge M.C.M. de Kok, Piret Veerus, Ahti Anttila, Sirpa HeinÃ¤vaara, Tytti Sarkeala, Marcell CsanÃ¡di, Janos Pitter, GyÃ¶rgy SzÃ©les, ZoltÃ¡n VokÃ³, Silvia Minozzi, Nereo Segnan, Carlo Senore, Marjolein van Ballegooijen, Inge Driesprong - de Kok, Andrea Gini, E
Effect of organised cervical cancer screening on cervical cancer mortality in Europe: a systematic review
published pages: 207-223, ISSN: 0959-8049, DOI: 10.1016/j.ejca.2019.12.013
|European Journal of Cancer 127||2020-04-15|
Andrea Gini, Erik E.L. Jansen, Nadine Zielonke, Reinier G.S. Meester, Carlo Senore, Ahti Anttila, Nereo Segnan, Dominika Novak Mlakar, Harry J. de Koning, Iris Lansdorp-Vogelaar, Piret Veerus, Ahti Anttila, Sirpa HeinÃ¤vaara, Tytti Sarkeala, Marcell CsanÃ¡di, Janos Pitter, GyÃ¶rgy SzÃ©les, ZoltÃ¡n VokÃ³, Silvia Minozzi, Nereo Segnan, Carlo Senore, Marjolein van Ballegooijen, Inge Driesprong - de K
Impact of colorectal cancer screening on cancer-specific mortality in Europe: A systematic review
published pages: 224-235, ISSN: 0959-8049, DOI: 10.1016/j.ejca.2019.12.014
|European Journal of Cancer 127||2020-04-15|
Nadine Zielonke, Andrea Gini, Erik E.L. Jansen, Ahti Anttila, Nereo Segnan, Antonio Ponti, Piret Veerus, Harry J. de Koning, Nicolien T. van Ravesteyn, Eveline A.M. Heijnsdijk, Piret Veerus, Ahti Anttila, Sirpa HeinÃ¤vaara, Tytti Sarkeala, Marcell CaÃ±ada, Janos Pitter, GyÃ¶rgy SzÃ©les, Zoltan Voko, Silvia Minozzi, Nereo Segnan, Carlo Senore, Marjolein van Ballegooijen, Inge Driesprong - de Kok, A
Evidence for reducing cancer-specific mortality due to screening for breast cancer in Europe: A systematic review
published pages: 191-206, ISSN: 0959-8049, DOI: 10.1016/j.ejca.2019.12.010
|European Journal of Cancer 127||2020-04-15|
Eveline A. M. Heijnsdijk, Marcell CsanÃ¡di, Andrea Gini, Kevin ten Haaf, Rita Bendes, Ahti Anttila, Carlo Senore, Harry J. de Koning
Allâ€cause mortality versus cancerâ€specific mortality as outcome in cancer screening trials: A review and modeling study
published pages: , ISSN: 2045-7634, DOI: 10.1002/cam4.2476
Jennifer Priaulx, Marcell CsanÃ¡di, Harry J. de Koning, Martin McKee
A choice experiment to identify the most important elements of a successful cancer screening program according to those who research and manage such programs
published pages: e34-e45, ISSN: 0749-6753, DOI: 10.1002/hpm.2697
|The International Journal of Health Planning and Management 34/1||2019-11-06|
Eleanor Turnbull, Jennifer Priaulx, Nicolien T. van Ravesteyn, Sirpa HeinÃ¤vaara, Ilona Siljander, Carlo Senore, Nereo Segnan, ZoltÃ¡n VokÃ³, Judit HagymÃ¡sy, Katja Jarm, Piret Veerus, Harry J. de Koning, Martin McKee
A health systems approach to identifying barriers to breast cancer screening programmes. Methodology and application in six European countries
published pages: , ISSN: 0168-8510, DOI: 10.1016/j.healthpol.2018.08.003
Eleanor Turnbull, Jennifer Priaulx, Inge M.C.M. de Kok, Iris Lansdorp-Vogelaar, Ahti Anttila, Tytti Sarkeala, Carlo Senore, Nereo Segnan, Marcell CsanÃ¡di, JÃ¡nos Pitter, Dominika Novak Mlakar, Urska Ivanus, Piret Veerus, Harry J. de Koning, Martin McKee
Results of a health systems approach to identify barriers to population-based cervical and colorectal cancer screening programmes in six European countries
published pages: , ISSN: 0168-8510, DOI: 10.1016/j.healthpol.2018.08.005
Jennifer Priaulx, Harry J. de Koning, Inge M.C.M. de Kok, GyÃ¶rgy SzÃ©les, Martin McKee
Identifying the barriers to effective breast, cervical and colorectal cancer screening in thirty one European countries using the Barriers to Effective Screening Tool (BEST)
published pages: , ISSN: 0168-8510, DOI: 10.1016/j.healthpol.2018.08.004
Maiju Pankakoski, Sirpa HeinÃ¤vaara, Tytti Sarkeala, Ahti Anttila
High lifetime probability of screen-detected cervical abnormalities
published pages: 96914131668574, ISSN: 0969-1413, DOI: 10.1177/0969141316685740
|Journal of Medical Screening||2019-11-06|
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EU-TOPIA" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "EU-TOPIA" are provided by the European Opendata Portal: CORDIS opendata.
Developing a diverse portfolio of vaccine candidates for Rift Valley Fever, Chikungunya and EbolaRead More
European platforM to PromOte Wellbeing and HEalth in the woRkplaceRead More
Gut OncoMicrobiome Signatures (GOMS) associated with cancer incidence, prognosis and prediction of treatment response.Read More